Ann: Chairman and Managing Director - AGM address, page-96

okay, it is pretty clear that Covid impacted the business both last year and in September of this year

so for those worried about any ongoing impact, I have just read the most interesting article in the Lancet..
apparently giving fluvoxamine (an SSRI antidepressant) in a dose of 100mg twice daily for 10 days in non-vaccinated subjects,
reduces hospitalisation rate by 66% and death rate by 91%

fluvoxamine is a standard serotonin re-uptake inhibitor antidepressant, but one which also has some anti-inflammatory properties.. it has been around for years.. it has a good side effect profile and is very cheap (as drugs go)..
the authors of the article think it could become the standard of care

so as I previously mentioned, the issue of covid and its impact upon society / hospitals / and even Poly is going to become less and less of an issue as we go forward